Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?

Ramos-Martín V, González-Martínez C, Mackenzie I, Schmutzhard J, Pace C, Lalloo DG, Terlouw DJ.

Am J Trop Med Hyg. 2014 Jul;91(1):62-73. doi: 10.4269/ajtmh.13-0702. Epub 2014 May 27. Review.

2.

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.

Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.

Malar J. 2009 Jun 8;8:125. doi: 10.1186/1475-2875-8-125.

3.

Artemisinin derivatives and malaria: useful, in combination with other antimalarials.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):162-8.

PMID:
19492494
4.

Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, Nigeria.

Meremikwu MM, Odey F, Oringanje C, Oyo-Ita A, Effa E, Esu EB, Eyam E, Oduwole O, Asiegbu V, Alaribe A, Ezedinachi EN.

Malar J. 2012 Dec 11;11:413. doi: 10.1186/1475-2875-11-413.

5.

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.

Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.

Malar J. 2009 May 19;8:107. doi: 10.1186/1475-2875-8-107.

6.

Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.

Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, Arinaitwe E, Tappero JW, Kaharuza F, Kamya MR, Dorsey G.

Malar J. 2014 Jan 28;13:32. doi: 10.1186/1475-2875-13-32.

7.

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.

Gargano N, Ubben D, Tommasini S, Bacchieri A, Corsi M, Bhattacharyya PC, Rao BH, Dubashi N, Dev V, Ghosh SK, Kumar A, Srivastava B, Valecha N.

Malar J. 2012 Jul 20;11:233. doi: 10.1186/1475-2875-11-233.

8.

Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.

Adjei GO, Goka BQ, Binka F, Kurtzhals JA.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):669-81. doi: 10.1586/eri.09.53. Review.

PMID:
19681693
9.
10.

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India.

Anvikar AR, Sharma B, Shahi BH, Tyagi PK, Bose TK, Sharma SK, Srivastava P, Srivastava B, Kiechel JR, Dash AP, Valecha N.

Malar J. 2012 Mar 30;11:97. doi: 10.1186/1475-2875-11-97.

11.

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.

Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR.

Malar J. 2009 Mar 16;8:48. doi: 10.1186/1475-2875-8-48.

12.

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.

Held J, Supan C, Salazar CL, Tinto H, Bonkian LN, Nahum A, Moulero B, Sié A, Coulibaly B, Sirima SB, Siribie M, Otsyula N, Otieno L, Abdallah AM, Kimutai R, Bouyou-Akotet M, Kombila M, Koiwai K, Cantalloube C, Din-Bell C, Djeriou E, Waitumbi J, Mordmüller B, Ter-Minassian D, Lell B, Kremsner PG.

Lancet Infect Dis. 2015 Dec;15(12):1409-19. doi: 10.1016/S1473-3099(15)00079-1. Epub 2015 Sep 3.

PMID:
26342427
13.

Artemisinin resistance or artemisinin-based combination therapy resistance?

Wongsrichanalai C.

Lancet Infect Dis. 2013 Feb;13(2):114-5. doi: 10.1016/S1473-3099(12)70349-3. No abstract available.

PMID:
23347632
14.

Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.

Sylla K, Abiola A, Tine RC, Faye B, Sow D, Ndiaye JL, Ndiaye M, Lo AC, Folly K, Ndiaye LA, Gaye O.

BMC Infect Dis. 2013 Dec 20;13:598. doi: 10.1186/1471-2334-13-598.

15.

Artemisinin-based combination treatment of falciparum malaria.

Nosten F, White NJ.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):181-92. Review.

PMID:
18165491
16.

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN.

Lancet. 2007 Mar 3;369(9563):757-65.

17.

Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.

Shah NK, Schapira A, Juliano JJ, Srivastava B, MacDonald PD, Poole C, Anvikar A, Meshnick SR, Valecha N, Mishra N.

Antimicrob Agents Chemother. 2013 Jul;57(7):2948-54. doi: 10.1128/AAC.00139-13. Epub 2013 Apr 15.

18.

Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.

Valecha N, Srivastava B, Dubhashi NG, Rao BH, Kumar A, Ghosh SK, Singh JP, Kiechel JR, Sharma B, Jullien V, Dash AP, Taylor WR, Anvikar AR.

J Vector Borne Dis. 2013 Dec;50(4):258-64.

19.

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ.

Lancet Infect Dis. 2010 Oct;10(10):673-81. doi: 10.1016/S1473-3099(10)70187-0. Epub 2010 Sep 9.

20.

Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.

Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM.

Lancet Infect Dis. 2012 Nov;12(11):851-8. doi: 10.1016/S1473-3099(12)70181-0. Epub 2012 Aug 30.

Supplemental Content

Support Center